Schenkein David P
Director | Chief Executive Officer
3 companies
Insider Signal Score
59
GoodTrades Analyzed
11
12M Win Rate
45.5%
Avg 3M Return
-0.6%
Avg 12M Return
-3.5%
Schenkein David P is a Director at AGIOS PHARMACEUTICALS, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $5.2M based on current market prices.
Holdings by Company
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2024 | DNLI Denali Therapeutics Inc. | Director | Sale+OE | 59,441 | $32.51 | $1,932,665.05 | -53.9% | -33.9% | -44.3% | |
| Feb 27, 2024 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 69,329 | $34.67 | $2,403,591.99 | -22.0% | +11.5% | -1.1% | |
| Feb 26, 2024 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 68,142 | $33.09 | $2,254,950.64 | -21.7% | +18.1% | +7.1% | |
| Apr 3, 2023 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 16,363 | $22.85 | $373,894.55 | -12.2% | +24.1% | +26.3% | |
| Mar 27, 2023 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 20,000 | $22.15 | $443,000.00 | -14.5% | +23.5% | +30.6% | |
| Mar 13, 2023 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 20,000 | $22.49 | $449,816.75 | -7.8% | +15.3% | +33.9% | |
| Feb 27, 2023 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 20,000 | $25.37 | $507,400.00 | -14.5% | +0.2% | +37.8% | |
| Feb 13, 2023 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 20,000 | $28.62 | $572,400.00 | -14.5% | -9.4% | -13.0% | |
| Jan 30, 2023 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 20,000 | $29.33 | $586,578.00 | -7.7% | -20.6% | -21.7% | |
| Jan 17, 2023 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 20,000 | $28.85 | $577,092.78 | -7.8% | -21.0% | -23.9% |
Page 1Next →